Register

I agree with the Privacy Policy

Los Angeles Times

Medical giant Medtronic to buy rival Covidien for $42.9 billion

June 15, 2014

Because both companies already are giants in the medical-devices market, the merger should allow for more robust research and development and more comprehensive health-monitoring capabilities, said Harry Wang, a health industry analyst at product research firm Parks Associates.

The medical devices industry has been plagued by slow innovation, but the merger should advance the market, Wang said.

“By buying up this company and consolidating R&D spending, they have a better chance of getting their products to market,” he said. “Over the long term, if R&D is spent wisely and effectively, you will see more cost-effective products for consumers.”

From the article, "Medical giant Medtronic to buy rival Covidien for $42.9 billion" by Javier Panzar.

Previously In The News

Crackdown on Piracy Hits Barrier

John Barrett, an analyst at market research firm Parks Associates in Dallas, is more skeptical. At a recent conference in Universal City, he asked a panel of college students about file sharing and...

Moving to Cut TV's Ties to the Living Room Set

According to the technology research firm Parks Associates, more than 30% of all U.S. households had high-speed Internet connection by the end of last year, and more than 15% had home networks. Mea...

High-Tech Industry Plugs Into Simplicity

The consumer electronics industry figures devices that can be set up in a home network — PCs, televisions and stereos that can talk to one another and share high-quality data, video and audio — are...

‹
1
2
3
4
5
6
7
8
9
10